Larvol Delta - 4Moving-Biotech-Granted-FDA-Fast-Track-Designation-to-4P004-Supporting-an-Accelerated-Development-Pathway-in-Knee-Osteoarthritis

liraglutide (4P004) - 4P-Pharma

https://www.businesswire.com/news/home/20260421591087/en/4Moving-Biotech-Granted-FDA-Fast-Track-Designation-to-4P004-Supporting-an-Accelerated-Development-Pathway-in-Knee-Osteoarthritis

Apr 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next